AS

Atul Sharma

Active Director Director DIN 10236597
DIN 10236597 First appointment Aug 2023 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2023
Shareholding value •••• Premium profile

About Atul Sharma

Data last updated:

Atul Sharma is a Director at Trueglam Pharmaceuticals Private Limited (since 2023). The company operates in Pharma. Trueglam Pharmaceuticals Private Limited reported revenue of ₹14.9 Lakh (FY 2025).

DIN 10236597
Primary Designation Director
Industry Pharma
First Appointment 23 Aug 2023
Oldest Company Age 3 yrs
Largest company Trueglam Pharmaceuticals Private Limited · ₹14.9 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director23 Aug 20232023₹14.9 Lakh (FY 2025)Active

Directorship timeline

Open interactive timeline →
Trueglam Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Atul Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Atul Sharma

Atul Sharma currently holds 1 directorship: Trueglam Pharmaceuticals Private Limited (Director, since 23 Aug 2023, revenue ₹14.9 Lakh (FY 2025)).

Atul Sharma was first appointed on 23 Aug 2023 as Director at Trueglam Pharmaceuticals Private Limited.

The current boards of Atul Sharma's companies include Renu Sharma (Trueglam Pharmaceuticals Private Limited), Saurabh . Bansal (Trueglam Pharmaceuticals Private Limited), Umesh Chand Garg (Trueglam Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available